Status:

COMPLETED

Research on the Nature, Diagnosis, and Treatment of Obesity and Diabetes

Lead Sponsor:

Rockefeller University

Conditions:

Insulin Resistance

Obesity

Eligibility:

All Genders

21-45 years

Brief Summary

The purpose of this study is to determine whether the level of FOXA2 expression in fat tissue is a biomarker of insulin resistance. To test this hypothesis, we will perform euglycemic-hyperinsulinemic...

Detailed Description

The investigators at Rockefeller University Hospital are engaged in research on the nature, diagnosis and treatment of obesity and diabetes. The investigators are trying to find out why insulin, a blo...

Eligibility Criteria

Inclusion

  • Healthy individuals
  • Age 21-45 years old
  • BMI: either \< 25, or 30-35, or \> 40
  • All patients must be willing and able to sign an informed consent form -

Exclusion

  • Chronic illnesses other the than mild forms of illnesses related to obesity, such as hypertension, hyperlipidemia, and others, that do not require medical treatment
  • Diabetes mellitus previously diagnosed as per subject report or an abnormal 2 hour OGTT at screening
  • Chronic drug treatment for any medical condition
  • Active weight reduction of more than 7 pounds in the last 3 months
  • History of bleeding or blood clotting disorders
  • Subjects with hemoglobin \<8.5 gm/dl
  • Changes in smoking habits for the last 6 months
  • Current pregnancy or current breast-feeding in women
  • Allergic reaction to local anesthetics
  • History of anaphylaxis or anaphylactic-like reactions
  • Tendency to form scars (keloids) easily
  • Irregular menses
  • HIV and hepatitis B or C positive subjects -

Key Trial Info

Start Date :

September 1 2005

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

April 1 2010

Estimated Enrollment :

14 Patients enrolled

Trial Details

Trial ID

NCT00229268

Start Date

September 1 2005

End Date

April 1 2010

Last Update

June 1 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rockefeller University Hospital

New York, New York, United States, 10021